IMCLONE SYSTEMS INC/DE
S-3, EX-23.1, 2000-11-09
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: IMCLONE SYSTEMS INC/DE, S-3, EX-5.1, 2000-11-09
Next: IMCLONE SYSTEMS INC/DE, S-3, EX-23.3, 2000-11-09



<PAGE>   1

                                                                  EXHIBIT 23.1
                              ACCOUNTANTS' CONSENT

The Board of Directors
ImClone System Incorporated:

We consent to the use of our report incorporated herein by reference and to
the reference to our firm under the heading "Experts" in the prospectus.


                                                                 /s/ KPMG LLP

Princeton, New Jersey
November 8, 2000





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission